Our News
The clinical advisory board will guide the company in the development of its autoimmune programs in demyelinating diseases …
Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative therapies for auto-immune and rare diseases, today announced the appointment of Paul F. Truex …
SATT1 Conectus and Find Therapeutics Sign Licensing Agreement to Develop a Promising New Therapy for Multiple Sclerosis
We are pleased to announce accomplished biotechnology executive and entrepreneur, Dr. Philippe Douville as its new Chief Executive …
Find Therapeutics, a new drug development company dedicated to breakthrough therapies against rare diseases launches in Montreal…